There is a constant pressure on the life sciences supply chain to tackle multiple challenges, such as rising cost, material shortage, varied demand, and the changing global dynamics. In the past few years, there has been a huge disruption in the life sciences industry that required a new and dynamic approach. Along with this, changing needs of patients, regulatory requirements, and personalized therapies have become equally important in this industry. So, life sciences leaders prioritized digital transformation to overcome multiple challenges and maintain market competitiveness.
Adoption of powerful solutions in the life sciences industry
There is increased adoption of digital tools and automation in the supply chain. Companies are investing heavily in cognitive planning, digital twins, and artificial intelligence (AI)-powered predictive analysis. These efforts are made to improve streamlining in the life sciences supply chain and get better business outcomes.
Driverless forecasting
When it comes to forecasting, digital automation has made a significant stride. It has minimized human error in forecasting data and enabled precise inventory management. This ensures supply chain management with fluctuating market demand.
Procurement Optimization
Life sciences organizations utilize historical performance data, market trends, and supplier metrics to improve supply chain processes. For instance, let us assume the case of oncology medicines: if the oncology marketing efforts show that there will be a potential increase in the demand for oncology medicines on the market, then life sciences optimize their procurement to meet market demand.
External disruption sensing
These days, life sciences companies are relying on real-time sensing tools. These tools are highly effective in assessing external factors that include geopolitical events and natural disasters that can make sudden changes in the drug market. This is a proactive approach that pays off well if utilized properly. Life sciences companies can make many important decisions with real-time sensing, such as operational adjustments, securing alternative supply channels, and rerouting logistics.
Route optimization for cell and gene therapy deliveries
AI-driven logistics systems are helpful in cell and gene therapy deliveries. They aid in optimizing delivery routes by using real-time data on traffic, weather, and other delivery constraints. In cell and gene therapy delivery, there are specific temperature control and handling requirements. So, AI-driven logistics systems ensure therapy is delivered to patients without any challenges. These systems provide the fastest and most cost-effective transportation routes that do not compromise the integrity of sensitive biological material.
A Positive Impact
Though life sciences companies have now adopted digitally transformative technologies. It has faced a lot of hurdles in the past, including a stringent regulatory environment, a complex cost structure, and the high upfront cost of drug development. However, today, it has gradually adopted the latest technologies that are giving fruitful business results. The implementation of these technological solutions has improved efficiency and transparency in the life sciences supply chain.
Life sciences companies have successfully optimized production processes to meet modern healthcare demands. Now, there is a huge push to digitize the entire ecosystem of life sciences. This has led to companies investing in AI to stay competitive. At this point, there are pockets of success when it comes to AI implementation. However, the adoption rate is still low due to implementation challenges. Life sciences companies are taking an innovative approach to take expert guidance and strategies from consulting firms to bridge the gap between potential and actual gains.
